(Q33640719)

28 July 2017

1 reference

title

Pharmacological control of rate and maintenance of sinus rhythm (English)

1 reference

28 July 2017

Ezekowitz MD

1

1 reference

28 July 2017

Lampert R

series ordinal

2

1 reference

28 July 2017

publication date

1 January 1999

1 reference

Journal of Thrombosis and Thrombolysis

28 July 2017

published in

1 reference

28 July 2017

volume

7

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

33-38

1 reference

A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group

28 July 2017

cites work

1 reference

12 December 2020

Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators

1 reference

12 December 2020

Disopyramide-Induced Torsade de Pointes

1 reference

12 December 2020

Managing chronic atrial fibrillation: a Markov decision analysis comparing warfarin, quinidine, and low-dose amiodarone

1 reference

12 December 2020

Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation.

1 reference

12 December 2020

Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter. The Diltiazem-Atrial Fibrillation/Flutter Study Group

1 reference

12 December 2020

Electropharmacology of sotalol in patients with Wolff-Parkinson-White syndrome

1 reference

12 December 2020

Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle

1 reference

12 December 2020

Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction

1 reference

12 December 2020

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

1 reference

12 December 2020

Antiarrhythmic drugs in the management of atrial fibrillation

1 reference

12 December 2020

Risk of initiating antiarrhythmic drug therapy for atrial fibrillation in patients admitted to a university hospital

1 reference

12 December 2020

Changes in left ventricular volume, mass, and function during the development and regression of supraventricular tachycardia-induced cardiomyopathy. Disparity between recovery of systolic versus diastolic function

1 reference

12 December 2020

Management of atrial fibrillation

1 reference

12 December 2020

A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: a multicenter study

1 reference

12 December 2020

QUINIDINE SYNCOPE. PAROXYSMAL VENTRICULAR FIBRILLATION OCCURRING DURING TREATMENT OF CHRONIC ATRIAL ARRHYTHMIAS.

1 reference

12 December 2020

Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter

1 reference

12 December 2020

Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin

1 reference

12 December 2020

Congestive heart failure caused by oral disopyramide

1 reference

12 December 2020

Efficacy, safety, and tolerance of d-sotalol in patients with refractory supraventricular tachyarrhythmias

1 reference

12 December 2020

Effects of intravenous diltiazem on rapid atrial fibrillation accompanied by congestive heart failure

1 reference

12 December 2020

Intravenous diltiazem for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure

1 reference

12 December 2020

Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group

1 reference

12 December 2020

Safety of long-term flecainide and propafenone in the management of patients with symptomatic paroxysmal atrial fibrillation: report from the Flecainide and Propafenone Italian Study Investigators

1 reference

12 December 2020

Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation

1 reference

12 December 2020

Comparative study of efficacy and safety of low-dose diltiazem or betaxolol in combination with digoxin to control ventricular rate in chronic atrial fibrillation: randomized crossover study

1 reference

12 December 2020

Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter.

1 reference

12 December 2020

The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm

1 reference

12 December 2020

Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators

1 reference

12 December 2020

Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension

1 reference

12 December 2020

Combined use of esmolol and digoxin in the acute treatment of atrial fibrillation or flutter

1 reference

12 December 2020

Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.

1 reference

12 December 2020

Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group

1 reference

12 December 2020

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.

1 reference

12 December 2020

Clinical course of recent-onset atrial fibrillation treated with oral propafenone

1 reference

12 December 2020

Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care

1 reference

12 December 2020

Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies

1 reference

12 December 2020

Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo.

1 reference

12 December 2020

Comparison of the efficacy and safety of esmolol, a short-acting beta blocker, with placebo in the treatment of supraventricular tachyarrhythmias. The Esmolol vs Placebo Multicenter Study Group

1 reference

12 December 2020

Ventricular rate control and exercise performance in chronic atrial fibrillation: effects of diltiazem and verapamil

1 reference

12 December 2020

Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine

1 reference

12 December 2020

Intravenous digoxin in acute atrial fibrillation. Results of a randomized, placebo-controlled multicentre trial in 239 patients. The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group

1 reference

12 December 2020

Atrial fibrillation 1992. Management strategies in flux

1 reference

12 December 2020

Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study

1 reference

12 December 2020

Long-term use of procaine amide following acute myocardial infarction

1 reference

12 December 2020

Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1008823202712

1 reference

Dimensions Publication ID

28 July 2017

1025511631

0 references

1 reference